Biocaptiva

BioCaptiva Ltd, headquartered in Edinburgh, Scotland, and led by CEO Jeremy Wheeler, is developing the BioCaptis, a medical device that has the potential to transform liquid biopsies into a powerful tool for cancer management by improving early disease diagnosis and monitoring, as well as enhancing clinical trial data for cancer patients.